Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene

International Journal of Antimicrobial Agents

Volumn 25, Issue 6, 2005, Pages 488-495

  Dobay, Orsolya ^a,b   Rozgonyi, Ferenc ^b   Amyes, Sebastian G B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Macrolide; mef; Mutations; Pneumococcus; Resistance determinants

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; PENICILLIN G; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD GROUP TYPING; CONTROLLED STUDY; GENE MUTATION; GENETIC STRAIN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RIBOSOME; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; GENES, BACTERIAL; GENES, RRNA; HUMANS; HUNGARY; MACROLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MUTATION; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 19544377333     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.02.010     Document Type: Article

References (41)

1. O. Dobay, F. Rozgonyi, E. Hajdú, E. Nagy, M. Knausz, and S.G.B. Amyes Antibiotic susceptibility testing and serotypes of Streptococcus pneumoniae isolates from Hungary J Antimicrob Chemother 51 2003 887 893
2. K. Nagai, P.C. Appelbaum, and T.A. Davies Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries Antimicrob Agents Chemother 46 2002 371 377
3. R. Leclercq, and P. Courvalin Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Minireview Antimicrob Agents Chemother 46 2002 2727 2734
4. M.C. Roberts, J. Sutcliffe, P. Courvalin, L.B. Jensen, J. Rood, and H. Seppälä Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants Antimicrob Agents Chemother 43 1999 2823 2830
5. D.J. Farrell, I. Morrissey, S. Bakker, and D. Felmingham Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study J Antimicrob Chemother 50 2002 39 47
6. F.J. Schmitz, M. Perdikouli, A. Beeck, J. Verhoef, and A.C. Fluit Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates Int J Antimicrob Agents 18 2001 433 436
7. C. Betriu, M. Redondo, and M.L. Palau Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci Antimicrob Agents Chemother 44 2000 1838 1841
8. G.A. Syrogiannopoulos, I.N. Grivea, and A. Tait-Kamradt Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece Antimicrob Agents Chemother 45 2001 342 344
9. H. Seppälä, M. Skurnik, H. Soini, M.C. Roberts, and P. Huovinen A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes Antimicrob Agents Chemother 42 1998 257 262
10. A. Tait-Kamradt, T.A. Davies, and P.C. Appelbaum Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America Antimicrob Agents Chemother 44 2000 3395 3401
11. J. Sutcliffe, A. Tait-Kamradt, and L. Wondrack Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system Antimicrob Agents Chemother 40 1996 1817 1824
12. M. Del Grosso, F. Ianelli, and C. Messina Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae J Clin Microbiol 40 2002 774 778
13. K. Gay, and D.S. Stephens Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae J Infect Dis 184 2001 56 65
14. M. Santagati, F. Ianelli, M.R. Oggioni, S. Stefani, and G. Pozzi Characterization of a genetic element carrying the macrolide efflux gene mefA in Streptococcus pneumoniae Antimicrob Agents Chemother 44 2000 2585 2587
15. P.V. Adrian, C. Mendrick, and D. Loebenberg Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants Antimicrob Agents Chemother 44 2000 3101 31016
16. A. Canu, B. Malbruny, M. Coquemont, T.A. Davies, P.C. Appelbaum, and R. Leclercq Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae Antimicrob Agents Chemother 46 2002 125 131
17. A. Tait-Kamradt, T.A. Davies, M. Cronan, M.R. Jacobs, P.C. Appelbaum, and J. Sutcliffe Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage Antimicrob Agents Chemother 44 2000 2118 2125
18. T.A. Davies, B.E. Dewasse, M.R. Jacobs, and P.C. Appelbaum In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae Antimicrob Agents Chemother 44 2000 414 417
19. R.N. Jones, D.J. Farrell, and I. Morrissey Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: Novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY Antimicrobial Surveillance Program Antimicrob Agents Chemother 47 2003 2696 2698
20. D.M. Musher, M.E. Dowell, and V.D. Shortridge Emergence of macrolide resistance during treatment of pneumococcal pneumonia N Engl J Med 346 2002 630 631
21. M. Pihlajamäki, J. Kataja, and H. Seppälä Ribosomal mutations in Streptococcus pneumoniae clinical isolates Antimicrob Agents Chemother 46 2002 654 658
22. R.R. Reinert, A. Wild, P.C. Appelbaum, R. Lütticken, M.Y. Cil, and A. Al-Lahham Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany Antimicrob Agents Chemother 47 2003 2319 2322
23. B. Bozdogan, P.C. Appelbaum, and L.M. Kelly Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten Central and Eastern European centers Clin Microbiol Infect 9 2003 653 661
24. D. Felmingham, R.N. Grüneberg, and Alexander Project Group The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections J Antimicrob Chemother 48 2000 191 203
25. K. Nagai, Y. Shibasaki, and K. Hasegawa Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and β-lactam resistance, and to detect common macrolide resistance determinants J Antimicrob Chemother 48 2001 915 918
26. J. Johnson, S. Bouchillon, and D. Pontani The effect of carbon dioxide on susceptibility testing of azithromycin, clarithromycin and roxithromycin against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes by broth microdilution and Etest: Artemis Project - first-phase study Clin Microbiol Infect 5 1999 327 330
27. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing; 12th Informational Supplement M100-S12 2002 NCCLS Wayne, PA, USA
28. G. Ackermann, and A.C. Rodloff Drugs of the 21st century: telithromycin (HMR 3647) - the first ketolide J Antimicrob Chemother 51 2003 497 511
29. J. Sutcliffe, T. Grebe, A. Tait-Kamradt, and L. Wondrack Detection of erythromycin-resistant determinants by PCR Antimicrob Agents Chemother 40 1996 2562 2566
30. P. Oster, A. Zanchi, and S. Cresti Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates Antimicrob Agents Chemother 43 1999 2510 2512
31. F. Walsh, J. Willcock, and S.G.B. Amyes High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae J Antimicrob Chemother 52 2003 345 353
32. F. Sanger DNA sequencing with chain-terminating inhibitors Proc Natl Acad Sci USA 74 1977 5463 5467
33. L.M.C. Hall, R.A. Whiley, B. Duke, R.C. George, and A. Efstratiou Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns J Clin Microbiol 34 1996 853 859
34. L. McGee, L. McDougal, and J. Zhou Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network J Clin Microb 39 2001 2565 2571
35. F. Depardieu, and P. Courvalin Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae Antimicrob Agents Chemother 45 2001 319 323
36. D.J. Farrell, and D. Felmingham Activities of telithromycin against 13874 Streptococcus pneumoniae isolates collected between 1999 and 2003 Antimicrob Agents Chemother 48 2004 1882 1884
37. Farrell DJ, Morrissey I, Bakker S, Buckridge S, Borger J, Felmingham D. Abstr. 43rd Intersci. Conf. Antimicrob. Agents Chemother.; 2003 [Abstract C2-69].
38. D.J. Farrell, I. Morrissey, and PROTEKT Study Group Clin Microbiol Infect 10 Suppl. 3 2004 314 [Abstract P1148]
39. Klugman KP. Abstr. 43rd Intersci. Conf. Antimicrob. Agents Chemother.; 2003 [Abstract L-461].
40. J.E. Powis, S. Pong-Porter, K. Green, J. Fuller, D.E. Low, and Canadian Bacterial Surveillance Network Clin Microbiol Infect 10 Suppl. 3 2004 494 [Abstract P1742]
41. Reinert RR, Appelbaum PC, Adler H, et al. Abstr. 42nd Intersci. Conf. Antimicrob. Agents Chemother.; 2002 [Abstract C2-1623].